Vaccine capital: Spotlight on Hyderabad; city set to produce a third of the world's dosage

Be it India’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FluGen’s CoroFlu or even Sanofi’s under development vaccine candidates, all have a Hyderabad connect.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZxOulg
via IFTTT